InsiderFlow

ENTX

Healthcare

Entera Bio Ltd.

$1.28-0.04 (-3.03%)

Prev Close

$1.32

Open

$1.35

High

$1.37

Low

$1.27

Volume

42.2K

Market Cap

$61.0M

P/E

—

Div Yield

—

Over the past 12 months, insider activity at Entera Bio Ltd. (ENTX) has been exclusively buying, with 1 insider purchase totaling $7.5K and 0 insider sales totaling $0.00. The most recent insider transaction was by Rubin Steven D (Director), who purchased $7.5K worth of shares on Feb 12, 2026. Entera Bio Ltd. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $61.0M.

Buys (12M)

1

$7.5K

Sells (12M)

0

$0.00

Net Activity

Net Buyer

$7.5K

Active Insiders

1

last 12 mo

ENTX Price Chart

ENTX Insider Trading Activity

DateInsiderRoleTypeSharesAvg PriceValueShares After
Feb 12, 2026↗Rubin Steven DDirectorBuy5,000$1.49$7.5K0
Jan 12, 2024↗Taitel HayaDirectorBuy9,500$0.99$9.4K35,115
Jan 10, 2024↗Taitel HayaDirectorBuy7,615$0.77$5.9K25,615
Dec 22, 2023↗LIEBERMAN GERALD MDirectorBuy23,952$0.71$17.0K226,961
Dec 22, 2023↗Toledano Miranda JayneChief Executive OfficerBuy23,952$0.71$17.0K110,752
Aug 22, 2023↗Taitel HayaDirectorBuy18,000$0.62$11.2K18,000
Aug 21, 2023↗Ellis SeanDirectorBuy40,000$0.60$24.0K102,100
Aug 21, 2023↗LIEBERMAN GERALD MDirectorBuy20,000$0.59$11.8K214,209
Apr 4, 2023↗Toledano Miranda JayneChief Executive OfficerBuy30,000$1.01$30.3K86,800
Nov 14, 2022↗LIEBERMAN GERALD MDirectorBuy42,000$0.57$24.0K194,209
Nov 11, 2022↗Ellis SeanDirectorBuy30,000$0.53$15.9K62,100
Nov 11, 2022↗Toledano Miranda JayneChief Executive OfficerBuy50,000$0.53$26.6K56,800
Nov 11, 2022↗Yaacov-Garbeli DanaChief Financial OfficerBuy56,580$0.53$29.8K56,580
Jul 21, 2022↗Ellis SeanDirectorBuy14,900$1.64$24.4K32,100
Jul 21, 2022↗LIEBERMAN GERALD MDirectorBuy19,491$1.68$32.8K160,209
Jan 20, 2022↗Schwartz PhillipPresident of R&DBuy10,000$2.53$25.3K607,410
Jan 19, 2022↗Ratan RameshU.S.based CFOBuy10,000$2.44$24.4K10,000
Jan 18, 2022↗Ellis SeanDirectorBuy10,000$2.81$28.1K10,000
Jan 18, 2022↗JAMAS SPIROSChief Executive OfficerBuy10,000$2.85$28.5K10,000
Jan 18, 2022↗LIEBERMAN GERALD MDirectorBuy2,100$2.80$5.9K2,200
Jan 18, 2022↗Mayron RonDirectorBuy7,000$2.80$19.6K7,000
Jan 14, 2022↗Toledano Miranda JayneDirectorBuy6,800$2.79$19.0K6,800
Jan 13, 2022↗Malca YonatanDirectorBuy7,232$2.74$19.8K7,232
Jan 13, 2022↗OSTROV GERALD MDirectorBuy10,000$2.74$27.4K10,000

ENTX Insider Buying Activity

The following table shows recent insider purchases of Entera Bio Ltd. (ENTX) stock reported via SEC Form 4 filings.

DateInsiderRoleTypeSharesAvg PriceValueShares After
Feb 12, 2026↗Rubin Steven DDirectorBuy5,000$1.49$7.5K0
Jan 12, 2024↗Taitel HayaDirectorBuy9,500$0.99$9.4K35,115
Jan 10, 2024↗Taitel HayaDirectorBuy7,615$0.77$5.9K25,615
Dec 22, 2023↗LIEBERMAN GERALD MDirectorBuy23,952$0.71$17.0K226,961
Dec 22, 2023↗Toledano Miranda JayneChief Executive OfficerBuy23,952$0.71$17.0K110,752
Aug 22, 2023↗Taitel HayaDirectorBuy18,000$0.62$11.2K18,000
Aug 21, 2023↗Ellis SeanDirectorBuy40,000$0.60$24.0K102,100
Aug 21, 2023↗LIEBERMAN GERALD MDirectorBuy20,000$0.59$11.8K214,209
Apr 4, 2023↗Toledano Miranda JayneChief Executive OfficerBuy30,000$1.01$30.3K86,800
Nov 14, 2022↗LIEBERMAN GERALD MDirectorBuy42,000$0.57$24.0K194,209
Nov 11, 2022↗Ellis SeanDirectorBuy30,000$0.53$15.9K62,100
Nov 11, 2022↗Toledano Miranda JayneChief Executive OfficerBuy50,000$0.53$26.6K56,800
Nov 11, 2022↗Yaacov-Garbeli DanaChief Financial OfficerBuy56,580$0.53$29.8K56,580
Jul 21, 2022↗Ellis SeanDirectorBuy14,900$1.64$24.4K32,100
Jul 21, 2022↗LIEBERMAN GERALD MDirectorBuy19,491$1.68$32.8K160,209
Jan 20, 2022↗Schwartz PhillipPresident of R&DBuy10,000$2.53$25.3K607,410
Jan 19, 2022↗Ratan RameshU.S.based CFOBuy10,000$2.44$24.4K10,000
Jan 18, 2022↗Ellis SeanDirectorBuy10,000$2.81$28.1K10,000
Jan 18, 2022↗JAMAS SPIROSChief Executive OfficerBuy10,000$2.85$28.5K10,000
Jan 18, 2022↗LIEBERMAN GERALD MDirectorBuy2,100$2.80$5.9K2,200
Jan 18, 2022↗Mayron RonDirectorBuy7,000$2.80$19.6K7,000
Jan 14, 2022↗Toledano Miranda JayneDirectorBuy6,800$2.79$19.0K6,800
Jan 13, 2022↗Malca YonatanDirectorBuy7,232$2.74$19.8K7,232
Jan 13, 2022↗OSTROV GERALD MDirectorBuy10,000$2.74$27.4K10,000

ENTX Insider Selling Activity

The following table shows recent insider sales of Entera Bio Ltd. (ENTX) stock reported via SEC Form 4 filings.

No insider selling activity found for ENTX in the last 12 months.

ENTX Insiders

Rubin Steven D

Director

Bought $7.5K
1 tradesLast: Feb 12, 2026
Taitel Haya

Director

Bought $26.5K
3 tradesLast: Jan 12, 2024
LIEBERMAN GERALD M

Director

Bought $91.4K
9 tradesLast: Dec 22, 2023
Toledano Miranda Jayne

Chief Executive Officer

Bought $73.9K
3 tradesLast: Dec 22, 2023
Ellis Sean

Director

Bought $92.4K
4 tradesLast: Aug 21, 2023
Yaacov-Garbeli Dana

Chief Financial Officer

Bought $29.8K
2 tradesLast: Nov 14, 2022
Schwartz Phillip

President of R&D

Bought $25.3K
1 tradesLast: Jan 20, 2022
Ratan Ramesh

U.S.based CFO

Bought $24.4K
1 tradesLast: Jan 19, 2022
JAMAS SPIROS

Chief Executive Officer

Bought $28.5K
1 tradesLast: Jan 18, 2022
Mayron Ron

Director

Bought $19.6K
1 tradesLast: Jan 18, 2022
Toledano Miranda Jayne

Director

Bought $19.0K
1 tradesLast: Jan 14, 2022
Malca Yonatan

Director

Bought $19.8K
1 tradesLast: Jan 13, 2022
OSTROV GERALD M

Director

Bought $27.4K
1 tradesLast: Jan 13, 2022

Similar Stocks to ENTX

VRTX

Vertex Pharmaceuticals Incorporated

$470.20-1.66%

$121.44B

REGN

Regeneron Pharmaceuticals, Inc.

$743.51-0.41%

$77.57B

ALNY

Alnylam Pharmaceuticals, Inc.

$313.45-1.19%

$42.07B

INSM

Insmed Incorporated

$139.06-0.33%

$30.07B

UTHR

United Therapeutics Corporation

$536.12+0.97%

$23.50B

MRNA

Moderna, Inc.

$52.56-1.89%

$20.76B

ROIV

Roivant Sciences Ltd.

$28.06-1.44%

$20.08B

RPRX

Royalty Pharma plc

$45.65-0.57%

$19.56B

Related Insider Trading Data

Healthcare Sector Insider TradingBiotechnology Insider TradingInsider BuyingCEO PurchasesCluster BuysWhat Is Insider Trading?